(Q46396909)

21 December 2017

https://github.com/jmillanacosta/retractable/blob/e28dcac33244e89948fe17fb65f09b59e2ed804d/data/PMIDS_DOIS.csv

1 reference

title

Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology (English)

1 reference

21 December 2017

0 references

1 reference

A M Badawy

1

1 reference

21 December 2017

M Khiary

2

1 reference

21 December 2017

L S Sherif

3

1 reference

21 December 2017

M Hassan

4

1 reference

21 December 2017

A Ragab

5

1 reference

21 December 2017

I Abdelall

6

1 reference

21 December 2017

publication date

1 April 2008

1 reference

21 December 2017

Journal of Obstetrics and Gynaecology

published in

1 reference

21 December 2017

volume

28

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

280-284

1 reference

21 December 2017

Preconceptional natural-killer-cell activity as a predictor of miscarriage

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Antiphospholipid syndrome: obstetric diagnosis, management, and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Future pregnancy outcome in unexplained recurrent first trimester miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Vascular endothelial growth factor is a chemoattractant for trophoblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Heparin-binding EGF-like growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Inherited thrombophilias in pregnant patients: detection and treatment paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

A novel attribute of enoxaparin: inhibition of monocyte adhesion to endothelial cells by a mechanism involving cell adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Mutations in coagulation factors in women with unexplained late fetal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Thrombophilic disorders and fetal loss: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Factor V Leiden mutation as a risk factor for recurrent pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Heparan sulfate proteoglycans in glomerular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Genetic susceptibility to venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Complement. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802042688

Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1080/01443610802042688

Updated and revised nomenclature for description of early pregnancy events

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1080/01443610802042688

Prevention of pre-eclampsia by early antiplatelet therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1080/01443610802042688

Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1080/01443610802042688

Identifiers

DOI

10.1080/01443610802042688

1 reference

21 December 2017

1 reference

21 December 2017